Q-Line Biotech Ltd

NSE: QLINE

₹411.50

up-down-arrow ₹-37.10 (-8.27%)

As on 18-Nov-2026IST

Market cap

info icon

₹960 Cr

Revenue (TTM)

info icon

₹342 Cr

P/E Ratio

info icon

17.2

P/B Ratio

info icon

3.8

Div. Yield

info icon

0 %

Q-Line Biotech Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 408.00 High: 454.95

52 Week Range

Low: 408.00 High: 735.00

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹56 Cr

  • ROEROE information

    25.6 %

  • ROCEROCE information

    22.2 %

  • Industry P/EIndustry P/E information

    51.44

  • EV/EBITDAEV/EBITDA information

    10.7

  • Debt to EquityDebt to Equity information

    0.9

  • Book ValueBook Value information

    ₹151.3

  • EPSEPS information

    ₹34.2

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    23,328,199

Years Aggregate

CFO

₹--

EBITDA

₹--

Net Profit

₹--

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Q-Line Biotech
-- -34.6 -22.2 -- -- -- --
BSE Healthcare
21.3 9.1 3.9 17.3 21.3 15.6 13.4
As on 18-Nov-2026
The underlying data is unavailable.

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Q-Line Biotech
411.5 960.0 341.7 55.7 -- 25.6 17.2 3.8
277.4 185.0 34.7 -6.0 -15.0 -37.7 -- 17.0
122.6 233.4 55.1 5.1 -- 7.7 45.8 3.4
239.5 131.4 52.5 8.8 -- 32.4 15 4.0
102.0 140.3 43.1 6.6 -- 40.6 28.4 2.2
302.4 282.4 173.9 4.8 2.2 2.6 59.3 1.5
1,654.5 16,753.5 2,134.1 309.8 16.2 9.9 52.6 5.1
170.0 328.8 191.1 11.6 11.6 10.4 32.5 3.0
97.0 159.2 105.3 1.5 10.6 3.2 103.4 3.2
357.0 702.1 115.5 12.3 -- 11.8 57.1 6.2

Shareholding Pattern

View Details
loading...

News & Analysis

All News

No Review & Analysis are available.

About Q-Line Biotech

--

  • Incorporated

    2010

  • Chairman

    Saurabh Garg

  • Managing Director

    Saurabh Garg

  • Headquarters

    Lucknow, Uttar Pradesh

  • Website

    www.qlinebiotech.com

FAQs for Q-Line Biotech

The share price of Q-Line Biotech Ltd is ₹411.50 (NSE) as of 18-Nov-2026 IST. Q-Line Biotech Ltd has given a return of --% in the last 1 years.

The P/E ratio of Q-Line Biotech Ltd is 17.23 times as on 18-Nov-2026, a 67 discount to its peers’ median range of 51.44 times.
The P/B ratio of Q-Line Biotech Ltd is 3.79 times as on 18-Nov-2026, a 15 premium to its peers’ median range of 3.29 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2026
0.00
0.00
2025
0.00
0.00
2024
0.00
0.00
2023
0.00
0.00
2026
0.00
0.00

The 52-week high and low of Q-Line Biotech Ltd are Rs 735.00 and Rs 408.00 as of 19-Nov-2026.

Q-Line Biotech Ltd has a market capitalisation of ₹ 960 Cr as on 18-Nov-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Q-Line Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month